Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Stock, Common [Member]	Noncontrolling Interest [Member]	Total
Balance at Dec. 31, 2022	$ 2,695	$ 6	$ 216,195	$ (228,169)	$ (408)	$ 20,615	$ 10,934
Balance, shares at Dec. 31, 2022	1,205,759	6,300,703
Balance at Jun. 30, 2023	$ 2,841	$ 7	226,423	(260,783)		30,682	(830)
Balance, shares at Jun. 30, 2023	1,254,497	7,235,867
Balance at Dec. 31, 2022	$ 2,695	$ 6	216,195	(228,169)	(408)	20,615	10,934
Balance, shares at Dec. 31, 2022	1,205,759	6,300,703
Dividends declared - Series B Convertible Preferred Stock	$ 221			(221)
Dividends declared - Series B Convertible Preferred Stock, shares	73,842
Issue common stock - PAVM ATM Facility			1,166				1,166
Issue common stock - PAVM ATM Facility, shares		155,384
Vest - restricted stock awards
Vest - restricted stock awards, shares		6,666
Conversions - Senior Secured Convertible Note		$ 2	8,409				8,411
Conversions - Senior Secured Convertible Note, shares		1,358,896
Conversions - subsidiary common stock - Senior Secured Convertible Note						167	167
Impact of subsidiary equity transactions			1,984			(1,984)
Issuance - vendor service agreement			600			147	747
Issuance - vendor service agreement, shares		100,000
Stock-based compensation - PAVmed Inc.			3,266				3,266
Net Loss				(50,139)		(11,716)	(61,855)
Purchase - Employee Stock Purchase Plan			198		60		258
Purchase - Employee Stock Purchase Plan, shares		45,892
Purchase - subsidiary common stock - Employee Stock Purchase Plan						551	551
Stock-based compensation - subsidiaries			876			5,029	5,905
Issuance - subsidiary common stock - Committed Equity Facility, net of financing charges						284	284
Issuance - subsidiary common stock - Settlement APA-RDx - Installment Payment						713	713
Issuance - subsidiary preferred stock (Series A)						13,625	13,625
Treasury stock			(348)		348
Treasury stock, shares		12,589
Balance at Sep. 30, 2023	$ 2,916	$ 8	232,346	(278,529)		27,431	(15,828)
Balance, shares at Sep. 30, 2023	1,279,601	7,980,131
Balance at Dec. 31, 2022	$ 2,695	$ 6	216,195	(228,169)	(408)	20,615	10,934
Balance, shares at Dec. 31, 2022	1,205,759	6,300,703
Balance at Dec. 31, 2023	$ 2,993	$ 9	237,600	(294,433)		29,813	(24,018)
Balance, shares at Dec. 31, 2023	1,305,213	8,578,505
Balance at Jun. 30, 2023	$ 2,841	$ 7	226,423	(260,783)		30,682	(830)
Balance, shares at Jun. 30, 2023	1,254,497	7,235,867
Dividends declared - Series B Convertible Preferred Stock	$ 75			(75)
Dividends declared - Series B Convertible Preferred Stock, shares	25,104
Conversions - Senior Secured Convertible Note		$ 1	3,988				3,989
Conversions - Senior Secured Convertible Note, shares		723,998
Conversions - subsidiary common stock - Senior Secured Convertible Note						167	167
Impact of subsidiary equity transactions			651			(651)
Stock-based compensation - PAVmed Inc.			978				978
Net Loss				(17,671)		(4,079)	(21,750)
Purchase - Employee Stock Purchase Plan			76				76
Purchase - Employee Stock Purchase Plan, shares		20,267
Stock-based compensation - subsidiaries			230			1,037	1,267
Purchase - majority-owned subsidiary common stock - Employee Stock Purchase Plan						275	275
Balance at Sep. 30, 2023	$ 2,916	$ 8	232,346	(278,529)		27,431	(15,828)
Balance, shares at Sep. 30, 2023	1,279,601	7,980,131
Balance at Dec. 31, 2023	$ 2,993	$ 9	237,600	(294,433)		29,813	(24,018)
Balance, shares at Dec. 31, 2023	1,305,213	8,578,505
Balance at Jun. 30, 2024	$ 3,151	$ 10	243,524	(320,630)		55,303	(18,642)
Balance, shares at Jun. 30, 2024	1,357,976	9,554,381
Balance at Dec. 31, 2023	$ 2,993	$ 9	237,600	(294,433)		29,813	(24,018)
Balance, shares at Dec. 31, 2023	1,305,213	8,578,505
Dividends declared - Series B Convertible Preferred Stock	$ 239			(239)
Dividends declared - Series B Convertible Preferred Stock, shares	79,936
Issue common stock - PAVM ATM Facility			977				977
Issue common stock - PAVM ATM Facility, shares		627,302
Vest - restricted stock awards
Vest - restricted stock awards, shares		135,080
Conversions - Senior Secured Convertible Note		$ 2	2,019				2,021
Conversions - Senior Secured Convertible Note, shares		1,084,366
Conversions - subsidiary common stock - Senior Secured Convertible Note						3,801	3,801
Impact of subsidiary equity transactions			4,414			(4,414)
Issuance - vendor service agreement			200			401	601
Issuance - vendor service agreement, shares		200,809
Stock-based compensation - PAVmed Inc.			2,228				2,228
Transfer of intellectual property to Lucid Diagnostics Inc			350				350
Deconsolidation of subsidiary						(56,339)	(56,339)
Net Loss				38,360		(11,075)	27,285
Exercise - stock options of subsidiary						4	4
Purchase - Employee Stock Purchase Plan			62				62
Purchase - Employee Stock Purchase Plan, shares		34,332
Purchase - subsidiary common stock - Employee Stock Purchase Plan						353	353
Issuance - subsidiary preferred stock (Series A-1)						5,670	5,670
Exchange - subsidiary preferred stock (Series A and Series A-1)						(24,294)	(24,294)
Issuance through exchange - subsidiary preferred stock (Series B and Series B-1)						31,790	31,790
Issuance through sale - subsidiary preferred stock (Series B and Series B-1)						24,129	24,129
Subsidiary deemed dividends on preferred stock attributable to noncontrolling interests						(7,496)	(7,496)
Stock-based compensation - subsidiaries			350			3,139	3,489
Balance at Sep. 30, 2024	$ 3,232	$ 11	248,200	(256,312)		(4,518)	(9,387)
Balance, shares at Sep. 30, 2024	1,385,149	10,660,394
Balance at Jun. 30, 2024	$ 3,151	$ 10	243,524	(320,630)		55,303	(18,642)
Balance, shares at Jun. 30, 2024	1,357,976	9,554,381
Dividends declared - Series B Convertible Preferred Stock	$ 81			(81)
Dividends declared - Series B Convertible Preferred Stock, shares	27,173
Issue common stock - PAVM ATM Facility			284				284
Issue common stock - PAVM ATM Facility, shares		294,003
Vest - restricted stock awards
Vest - restricted stock awards, shares		131,016
Conversions - Senior Secured Convertible Note		$ 1	907				908
Conversions - Senior Secured Convertible Note, shares		509,942
Conversions - subsidiary common stock - Senior Secured Convertible Note						1,260	1,260
Impact of subsidiary equity transactions			2,245			(2,245)
Issuance - vendor service agreement			150				150
Issuance - vendor service agreement, shares		171,052
Stock-based compensation - PAVmed Inc.			696				696
Stock-based compensation - subsidiary			44			1,191	1,235
Transfer of intellectual property to Lucid Diagnostics Inc			350				350
Deconsolidation of subsidiary						(56,339)	(56,339)
Net Loss				64,399		(3,688)	60,711
Balance at Sep. 30, 2024	$ 3,232	$ 11	$ 248,200	$ (256,312)		$ (4,518)	$ (9,387)
Balance, shares at Sep. 30, 2024	1,385,149	10,660,394